Qualified Participants Must:
Subjects have to be between the ages of 18 - 75 years of age
Must be diagnosed with ulcerative colitis for 90 days prior to receiving study medication and have to had an inadequate response to corticosteriods, immunosuppressants, and/or biologic therapies
Qualified Participants May Receive:
Those who qualify may receive compensation for there time and travel.